By considering the definitive role of COX-2, many COX-2 inhibitors were analyzed as a therapeutic modality against breast cancer and found to provide significant protection against breast cancer in various in vitro and murine animal studies9,10. This evidence concerns the gene PTGS2 and breast cancer.